Chinese Bioethicists: He Jiankui’s Crime is More than Illegal Medical Practice
By Ruipeng Lei and Renzong Qiu,
The Hastings Center Bioethics Forum
| 01. 04. 2020
Professionals and the public in China first learned of the jail sentence of He Jiankui from the report of Xinhua News Agency. No information, including any interpretation, was provided by the Court. But the reported words of the sentence are so ambiguous as to leave room for different interpretations. We believe that the public has the right to know more than Xinhua News Agency reported.
The Court blames He and his accomplices for “their deliberate violence of China’s relevant regulations and medical ethics,” “the application of human embryonic gene editing technologies for which safety and efficacy have not been proven to clinical practices of assisted reproduction,” and “their action going beyond the bottom line of research/clinical ethics.” All these offences violate administrative regulations and ethical norms, but none of them are illegal under China’s civil or criminal laws. However, in listing these ethical and administrative wrongdoings in the sentence, the court may have been trying to fill the legal gap; that is extraordinary, and it should be praised.
We feel relieved that the trial in this case followed procedural law...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...